ELANCO ANIMAL HEALTH INC
ELANNYSETrading Snapshot
- Day Range
- $22.46 β $22.87
- 52-Week Range
- $19.40 β $27.98
- Volume
- $3.18B
- Avg Volume
- $2.44B
- Shares Outstanding
- 499.4M
- Next Earnings
- Nov 20, 2026
Fundamentals Snapshot
- Annual Revenue
- $4.71B
- Last Q Revenue
- $1.37B
- P/E Ratio
- -55.1
- P/S Ratio
- 2.2x
- EPS (TTM)
- $-0.40
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +0.5%
Why Investors Own ELAN
- βHigh-growth profile β revenue up +12.3% YoY with expanding US Equity exposure.
- βHealthy economics β 36% gross margin and 12% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
ELANCO ANIMAL HEALTH INC
ELANAbout ELANCO ANIMAL HEALTH INC
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates

Elanco Animal Health Eyes Growth, Deleveraging as Quattro and Zenrelia Gain Ground
Elanco Animal Health NYSE: ELAN President and CEO Jeff Simmons outlined the company's growth strategy, product launches, deleveraging plans and outlook for its pet health and farm animal businesses during the Bank of Ame

State Street Corp Has $395.31 Million Holdings in Elanco Animal Health Incorporated $ELAN
State Street Corp grew its holdings in Elanco Animal Health Incorporated (NYSE: ELAN) by 4.7% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned

Elanco Animal Health Incorporated (ELAN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Elanco Animal Health Incorporated (ELAN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Analyzing Amarin (NASDAQ:AMRN) & Elanco Animal Health (NYSE:ELAN)
Elanco Animal Health (NYSE: ELAN - Get Free Report) and Amarin (NASDAQ: AMRN - Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength o

Elanco Animal Health Incorporated $ELAN Shares Acquired by Corient Private Wealth LP
Corient Private Wealth LP lifted its position in shares of Elanco Animal Health Incorporated (NYSE: ELAN) by 124.1% during the undefined quarter, according to its most recent disclosure with the SEC. The firm owned 342,2

Elanco to Participate in BofA Securities Global Healthcare Conference 2026
INDIANAPOLIS, Sept. 17, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the BofA Securities Global Healthcare Conference 2026 on September 22, 2026.